HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ban Al-Kurdi Selected Research

Type 2A2 Axonal Charcot-Marie-Tooth Disease

1/2022Generation of a human induced pluripotent stem cell (iPSC) line (JUCTCi019-A) from a patient with Charcot-Marie-Tooth disease type 2A2 (CMT2A2) due to a heterozygous missense substitution c.2119C > T (p.Arg707Trp) in MFN2 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ban Al-Kurdi Research Topics

Disease

1Type 2A2 Axonal Charcot-Marie-Tooth Disease
01/2022
1Glioma (Gliomas)
03/2021
1Neoplasms (Cancer)
03/2021
1Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital)
07/2020
1Hypersensitivity (Allergy)
01/2020
1Cerebellar Ataxia (Dysmetria)
01/2020

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
01/2022
1Cell ExtractsIBA
03/2021
1Conditioned Culture MediaIBA
03/2021
1Cholinergic ReceptorsIBA
07/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Etoposide (VP 16)FDA LinkGeneric
01/2020

Therapy/Procedure

1Therapeutics
03/2021